全球血液篩檢市場規模、佔有率、成長分析、按產品類型、最終用戶分類 - 產業預測，2024-2031 年

Global Blood Screening Market Size, Share, Growth Analysis, By Product Type(Reagents & Kits, Instruments), By End User(Hospitals & Clinics, Blood Banks) - Industry Forecast 2024-2031

出版日期: 2024年04月10日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球血液篩檢市場規模將為27.3億美元，預測期內（2024-2031年）年複合成長率為8.50%，從2023年的29.6億美元成長到2031年的29.6億美元。到美國9000萬美元。

用於血液篩檢的自動化分子平台在業界領先的公司中越來越受歡迎，並正在推動市場擴張。血液篩檢市場的成長是由幾個關鍵因素推動的，例如捐血和捐血數量的增加、對捐血安全意識的提高、感染疾病的迅速增加以及各種政府措施。根據 2021 年 12 月的報導《手術風險》，全球每年進行超過 2.34 億例大型手術，這進一步加劇了這一激增。此外，在難產期間經常使用輸血來解決急性兒童貧血、創傷和先天性母體血液異常等問題。此外，根據世界衛生組織（WHO）2021年6月情況說明書的資料，全球有1.185億次捐血，其中40%來自高所得國家。值得注意的是，捐血與收入水準的比率在高所得國家為31.5%，在中高收入國家為15.9%，在中低收入國家為6.8%，在低收入國家為5.0% ，差距就凸顯出來了。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Abbott Laboratories（USA）
Becton, Dickinson and Company（USA）
Bio-Rad Laboratories, Inc.（USA）
bioMA（C）rieux SA（France）
F. Hoffmann-La Roche Ltd.（Switzerland）
Grifols, SA（Spain）
Hologic, Inc.（USA）
Immucor, Inc.（USA）
Meridian Bioscience, Inc.（USA）
Ortho Clinical Diagnostics（USA）
Quotient Limited（UK）
Siemens Healthineers AG（Germany）
Sysmex Corporation（Japan）
Thermo Fisher Scientific Inc.（USA）
Danaher Corporation（USA）
Grifols Diagnostic Solutions Inc.（USA）
Haemonetics Corporation（USA）
Luminex Corporation（USA）
Natera, Inc.（USA）
Novartis International AG（Switzerland）
PerkinElmer, Inc.（USA）
Promega Corporation（USA）

簡介目錄

Product Code: SQMIG35J2044

Global Blood Screening Market size was valued at USD 2.73 Billion in 2022 and is poised to grow from USD 2.96 Billion in 2023 to USD 5.69 Billion by 2031, at a CAGR of 8.50% during the forecast period (2024-2031).

Automated molecular platforms for Blood Screening have become increasingly popular among leading industry players, driving market expansion. The growth of the Blood Screening market is fueled by several key factors including the escalating number of blood donations and donors, heightened awareness regarding the safety of donated blood, the surge in infectious diseases, and various governmental initiatives. This surge is further bolstered by the staggering volume of major surgeries conducted worldwide annually, surpassing 234 million according to the December 2021 article "Operative Risk". Additionally, blood transfusions are frequently administered in challenging childbirths to address issues like childhood acute anaemia, trauma, and congenital maternal blood abnormalities. Furthermore, data from the World Health Organization (WHO) Factsheet of June 2021 indicates that 118.5 million blood donations are made globally, with 40% originating from high-income countries, despite these countries only representing 16% of global blood donations. Notably, the proportion of donations relative to income levels highlights disparities, with high-income nations contributing 31.5%, upper-middle-income nations 15.9%, lower-middle-income nations 6.8%, and low-income nations 5.0%.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Screening Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Screening Market Segmental Analysis

Global Blood Screening Market is segmented on the basis of product type, end users and region. By product type, the market is segmented into reagents & kits, instruments, software. By end user, the market is segmented into hospitals & clinics, blood banks, diagnostic centers, and research laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Blood Screening Market

Healthcare professionals and patients are increasingly recognizing the potential dangers linked with blood transfusions, including the transmission of infectious diseases. Consequently, there is a rising need for blood screening products that guarantee the safety of both blood and blood-related products.

Restraints in the Global Blood Screening Market

The scarcity of phlebotomists, laboratory technicians, and other skilled workers in the industry could impede the widespread adoption of blood screening products. Healthcare institutions and blood banks may encounter difficulties in finding qualified personnel to operate the equipment and conduct tests, potentially limiting their ability to implement comprehensive blood screening programs.

Market Trends of the Global Blood Screening Market

The increasing demand for plasma-derived products like immunoglobulins and clotting factors is fueling the need for advanced blood screening tools to guarantee the safety of these products. This upward trajectory is projected to persist as the utilization of plasma-derived products extends into emerging therapeutic domains.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Blood Screening Market by Product Type

Market Overview
Reagents & Kits
Instruments
Software

Global Blood Screening Market by End User

Market Overview
Hospitals & Clinics
Blood Banks
Diagnostic Centers
Research Laboratories

Global Blood Screening Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMA(C)rieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immucor, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quotient Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols Diagnostic Solutions Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haemonetics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments